Geometric Mean Anti-CS Antibody Response Over Time.
- Alphonse Ouédraogo (209898)
- Alfred B. Tiono (209905)
- Désiré Kargougou (482827)
- Jean Baptiste Yaro (209836)
- Esperance Ouédraogo (5656834)
- Youssouf Kaboré (209882)
- David Kangoye (482828)
- Edith C. Bougouma (258144)
- Adama Gansane (5656837)
- Noelie Henri (482829)
- Amidou Diarra (209846)
- Souleymane Sanon (289842)
- Issiaka Soulama (209863)
- Amadou T. Konate (5651521)
- Nora L. Watson (289848)
- Valerie Brown (482830)
- Jenny Hendriks (482831)
- Maria Grazia Pau (113336)
- Isabella Versteege (482832)
- Edison Wiesken (482833)
- Jerald Sadoff (482834)
- Issa Nebie (3502823)
- Sodiomon B. Sirima (209926)
Publication date
November 2013
DOIAbstract
<p>Geomean anti-CS antibody titers are plotted per timepoint at baseline, 1 month after the first vaccination, 1 month after the second vaccination, 2 months after the second vaccination and at 1 and 2 months after the third vaccination. All dose groups results are shown (nr of samples assessed for any time point): placebo (7 to 8), 10<sup>9</sup> vp/ml (10), 10<sup>10</sup> vp/mL (9 to 10), 5x10<sup>10</sup> vp/mL (10) and 10<sup>11</sup> vp/mL (7 to 10). (v) designates vaccination on the study timescale, at month 0, 1 and 3. Krusal-Wallis tests were used to compare responses relative to placebo with * indicating p<0.01. EU are relative ELISA Units. The LLOQ is 18 EU/mL (dotted line).</p
Add to ORKG